Skip to Content

Boston Partners All Cap Value Inv BPAVX

Medalist Rating as of | See Boston Partners Investment Hub
  • NAV / 1-Day Return 32.77  /  +1.68 %
  • Total Assets 1.5 Bil
  • Adj. Expense Ratio
    1.050%
  • Expense Ratio 1.050%
  • Distribution Fee Level Above Average
  • Share Class Type No Load
  • Category Large Value
  • Investment Style Large Value
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield 1.27%
  • Turnover 33%

USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:12 PM GMT+0

Morningstar’s Analysis BPAVX

Will BPAVX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Strong execution of a solid approach.

Analyst Andrew Redden

Andrew Redden

Analyst

Summary

Strong execution of a robust, valuation-aware approach makes this an attractive offering.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BPAVX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 18.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Alphabet Inc Class A

2.66 37.7 Mil
Communication Services

JPMorgan Chase & Co

2.08 29.5 Mil
Financial Services

Johnson & Johnson

1.96 27.9 Mil
Healthcare

AbbVie Inc

1.83 25.9 Mil
Healthcare

CRH PLC

1.81 25.6 Mil
Basic Materials

Booking Holdings Inc

1.77 25.2 Mil
Consumer Cyclical

Corpay Inc

1.76 24.9 Mil
Technology

American International Group Inc

1.74 24.7 Mil
Financial Services

Bank of America Corp

1.68 23.9 Mil
Financial Services

Check Point Software Technologies Ltd

1.65 23.4 Mil
Technology